Your browser doesn't support javascript.
loading
LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway.
Wang, Hongying; Wang, Lei; Luan, Huiwen; Xiao, Jing; Zhao, Zhiling; Yu, Pengfei; Deng, Mi; Liu, Yifan; Ji, Shuhao; Ma, Junjie; Zhou, Yan; Zhang, Jiashen; Meng, Xianhui; Zhang, Juan; Zhao, Xinyu; Li, Chunling; Li, Fangmin; Wang, Dapeng; Wei, Shujuan; Hui, Lijun; Nie, Siman; Jin, Changzhu; An, Zhiqiang; Zhang, Ningyan; Wang, Yaopeng; Zhang, Cheng Cheng; Li, Zunling.
Afiliação
  • Wang H; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Wang L; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Luan H; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Xiao J; Department of Hematology, Yantaishan Hospital, Yantai, Shandong, 264003, P.R. China.
  • Zhao Z; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Yu P; Department of Biopharmaceutical, School of Pharmacy, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Deng M; Department of Physiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390, USA.
  • Liu Y; Peking University International Cancer Institute, Peking University, CN 38 Xueyuan Rd. Haidian Dis., Beijing, 100191, P.R. China.
  • Ji S; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Ma J; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Zhou Y; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264009, P.R. China.
  • Zhang J; Department of Gastrointestinalstrointestinal Surgery, Yantaishan Hospital, Yantai, Shandong, 264003, P.R. China.
  • Meng X; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Zhang J; Department of Biochemistry and Molecular Biology, School of Life Sciences, Shandong Agricultural University, Taian, Shandong, 271018, P.R. China.
  • Zhao X; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Li C; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Li F; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Wang D; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Wei S; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Hui L; Department of Pathophysiology, Bengbu Medical College, Anhui, 233000, P.R. China.
  • Nie S; R&D Center, Luye Pharma Group, Yantai, Shandong, 264005, P.R. China.
  • Jin C; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • An Z; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Zhang N; Department of Biochemistry and Molecular Biology, Shandong Tumour Immunotherapy Research Innovation Team, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
  • Wang Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, 77030, USA.
  • Zhang CC; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, 77030, USA.
  • Li Z; Department of Thoracic Surgery, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, 266011, P.R. China. qdwangyaopeng@163.com.
J Exp Clin Cancer Res ; 43(1): 183, 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38951916
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores Imunológicos / Transdução de Sinais / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores Imunológicos / Transdução de Sinais / Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2024 Tipo de documento: Article